Profiel
Leah Makley was the founder of Viewpoint Therapeutics, Inc., founded in 2014, and held the title of Chief Executive Officer.
Dr. Makley currently holds the positions of Chief Operations Officer at MBC Biolabs and Chief Operating Officer at Deciduous Therapeutics, Inc. since 2022.
Dr. Makley completed an undergraduate degree at the University of Dayton in 2009 and a doctorate at the University of Michigan in 2014.
Actieve functies van Leah Makley
| Bedrijven | Functie | Begin |
|---|---|---|
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Operationeel Directeur | 01-02-2022 |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Operationeel Directeur | - |
Eerdere bekende functies van Leah Makley
| Bedrijven | Functie | Einde |
|---|---|---|
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Algemeen Directeur | 01-02-2022 |
Opleiding van Leah Makley
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Health Technology |
MBC Biolabs
MBC Biolabs Miscellaneous Commercial ServicesCommercial Services Provides life science research and development services | Commercial Services |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism | Health Technology |
















